15 mg/ml tirzepatide Mounjaro 15mg x 1 vial Zepbound (Tirzepatide) 15mg/0.5mL Pre-Filled Pens
Description
GL5197E (Mounjaro) has a moderate Form Complexity Index of 60/100 111 fillable fields across 4 pages
It has the same active ingredient (liraglutide) as the diabetes drug Victoza, but at a higher dose - the maximum dose for Saxenda is 3 mg per day, while the maximum dose for Victoza is just 1.8 mg per day
Cost and Insurance Semaglutide treatments can be pricey
Tirzepatide produces greater average weight loss (17.60 kg versus 11.85 kg for semaglutide), and its dual-receptor mechanism provides theoretical advantages for insulin sensitization
Tirzepatide operates as a dual GIP and GLP-1 receptor agonist, making it a GLP-1 research peptide with expanded receptor reach
Cycle Length: Typically 812 weeks
